Neuraxpharm
HealthcareBiotech & Pharma
HQ: Düsseldorf, Germany
Investors: 2 (1 current, 1 exited)
A pharmaceutical company focused on central nervous system treatments sold to Permira in 2020.
Investors (2)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Permira | Current | - | - | Website |
| Apax Partners | Exited | - | - | Website |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get Signals